EC approves NewAmsterdam's obicetrapib drugs Ubeslo and Evlarco with Menarini
The European Commission authorized both obicetrapib products for cholesterol-lowering use, the first regulatory clearance for the drug worldwide.
SEC filing
2 stories
The European Commission authorized both obicetrapib products for cholesterol-lowering use, the first regulatory clearance for the drug worldwide.
SEC filing